Tollefson MK - Search Results

1

Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose?

Deol ES, Sharma V, Fadel AE, Vasdev R, Henning G, Basourakos S, Ghaffar U, Tollefson MK, Frank I, Houston Thompson R, Karnes RJ, Boorjian SA, Khanna A. Deol ES, et al. Among authors: tollefson mk. Urology. 2024 Dec;194:154-161. doi: 10.1016/j.urology.2024.08.055. Epub 2024 Aug 28. Urology. 2024. PMID: 39214499

2

In situ partial nephrectomy and tumor thrombectomy for renal cell carcinoma with level II vena cava extension in a solitary kidney.

Tollefson MK, Kawashima A, Blute ML. Tollefson MK, et al. Urology. 2005 Oct;66(4):882. doi: 10.1016/j.urology.2005.04.023. Urology. 2005. PMID: 16230173

3

Functional and oncological outcomes after orthotopic neobladder reconstruction in women.

Granberg CF, Boorjian SA, Crispen PL, Tollefson MK, Farmer SA, Frank I, Blute ML. Granberg CF, et al. Among authors: tollefson mk. BJU Int. 2008 Dec;102(11):1551-5. doi: 10.1111/j.1464-410X.2008.07909.x. Epub 2008 Oct 8. BJU Int. 2008. PMID: 18990170

4

Long-term outcome of ureterosigmoidostomy: an analysis of patients with >10 years of follow-up.

Tollefson MK, Elliott DS, Zincke H, Frank I. Tollefson MK, et al. BJU Int. 2010 Mar;105(6):860-3. doi: 10.1111/j.1464-410X.2009.08811.x. Epub 2009 Aug 13. BJU Int. 2010. PMID: 19681892

5

The effect of Gleason score on the predictive value of prostate-specific antigen doubling time.

Tollefson MK, Blute ML, Rangel LJ, Bergstralh EJ, Boorjian SA, Karnes RJ. Tollefson MK, et al. BJU Int. 2010 May;105(10):1381-5. doi: 10.1111/j.1464-410X.2009.08976.x. Epub 2009 Oct 26. BJU Int. 2010. PMID: 19863524

6

Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma.

Tollefson MK, Blute ML, Farmer SA, Frank I. Tollefson MK, et al. J Urol. 2010 Jan;183(1):81-6. doi: 10.1016/j.juro.2009.08.158. J Urol. 2010. PMID: 19913820

7

Radical prostatectomy for prostate cancer after ileal pouch-anal anastomosis offers oncologic control and sustains quality of life.

Umbreit EC, Dozois EJ, Crispen PL, Tollefson MK, Karnes RJ, Blute ML. Umbreit EC, et al. Among authors: tollefson mk. J Am Coll Surg. 2010 Feb;210(2):232-9. doi: 10.1016/j.jamcollsurg.2009.09.041. Epub 2009 Dec 3. J Am Coll Surg. 2010. PMID: 20113945

8

Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology?

Tollefson M, Magera J, Sebo T, Cohen J, Drauch A, Maier J, Frank I. Tollefson M, et al. BJU Int. 2010 Aug;106(4):484-8. doi: 10.1111/j.1464-410X.2010.09185.x. Epub 2010 Mar 1. BJU Int. 2010. PMID: 20201840

9

The impact of family history on pathological and clinical outcomes in non-syndromic clear cell renal cell carcinoma.

Tollefson MK, Boorjian SA, Lohse CM, Blute ML, Leibovich BC. Tollefson MK, et al. BJU Int. 2010 Dec;106(11):1638-42. doi: 10.1111/j.1464-410X.2010.09441.x. BJU Int. 2010. PMID: 20553256

10

Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy.

Tollefson MK, Blute ML, Rangel LJ, Karnes RJ, Frank I. Tollefson MK, et al. J Urol. 2010 Sep;184(3):925-9. doi: 10.1016/j.juro.2010.05.043. J Urol. 2010. PMID: 20643452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters